BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 27364155)

  • 1. Structural characterization suggests models for monomeric and dimeric forms of full-length ezrin.
    Phang JM; Harrop SJ; Duff AP; Sokolova AV; Crossett B; Walsh JC; Beckham SA; Nguyen CD; Davies RB; Glöckner C; Bromley EH; Wilk KE; Curmi PM
    Biochem J; 2016 Sep; 473(18):2763-82. PubMed ID: 27364155
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ezrin mutants affecting dimerization and activation.
    Chambers DN; Bretscher A
    Biochemistry; 2005 Mar; 44(10):3926-32. PubMed ID: 15751968
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insights into a single rod-like helix in activated radixin required for membrane-cytoskeletal cross-linking.
    Hoeflich KP; Tsukita S; Hicks L; Kay CM; Tsukita S; Ikura M
    Biochemistry; 2003 Oct; 42(40):11634-41. PubMed ID: 14529273
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structure of dimerized radixin FERM domain suggests a novel masking motif in C-terminal residues 295-304.
    Kitano K; Yusa F; Hakoshima T
    Acta Crystallogr Sect F Struct Biol Cryst Commun; 2006 Apr; 62(Pt 4):340-5. PubMed ID: 16582480
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structural basis for type II membrane protein binding by ERM proteins revealed by the radixin-neutral endopeptidase 24.11 (NEP) complex.
    Terawaki S; Kitano K; Hakoshima T
    J Biol Chem; 2007 Jul; 282(27):19854-62. PubMed ID: 17459884
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Crystal structure of the FERM domain of focal adhesion kinase.
    Ceccarelli DF; Song HK; Poy F; Schaller MD; Eck MJ
    J Biol Chem; 2006 Jan; 281(1):252-9. PubMed ID: 16221668
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thermodynamic dissection of the Ezrin FERM/CERMAD interface.
    Jayaraman B; Nicholson LK
    Biochemistry; 2007 Oct; 46(43):12174-89. PubMed ID: 17914868
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Open conformation of ezrin bound to phosphatidylinositol 4,5-bisphosphate and to F-actin revealed by neutron scattering.
    Jayasundar JJ; Ju JH; He L; Liu D; Meilleur F; Zhao J; Callaway DJ; Bu Z
    J Biol Chem; 2012 Oct; 287(44):37119-33. PubMed ID: 22927432
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structure of the active N-terminal domain of Ezrin. Conformational and mobility changes identify keystone interactions.
    Smith WJ; Nassar N; Bretscher A; Cerione RA; Karplus PA
    J Biol Chem; 2003 Feb; 278(7):4949-56. PubMed ID: 12429733
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structure of the ERM protein moesin reveals the FERM domain fold masked by an extended actin binding tail domain.
    Pearson MA; Reczek D; Bretscher A; Karplus PA
    Cell; 2000 Apr; 101(3):259-70. PubMed ID: 10847681
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural basis of the cytoplasmic tail of adhesion molecule CD43 and its binding to ERM proteins.
    Takai Y; Kitano K; Terawaki S; Maesaki R; Hakoshima T
    J Mol Biol; 2008 Sep; 381(3):634-44. PubMed ID: 18614175
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The EBP50-moesin interaction involves a binding site regulated by direct masking on the FERM domain.
    Finnerty CM; Chambers D; Ingraffea J; Faber HR; Karplus PA; Bretscher A
    J Cell Sci; 2004 Mar; 117(Pt 8):1547-52. PubMed ID: 15020681
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Unfurling of the band 4.1, ezrin, radixin, moesin (FERM) domain of the merlin tumor suppressor.
    Yogesha SD; Sharff AJ; Giovannini M; Bricogne G; Izard T
    Protein Sci; 2011 Dec; 20(12):2113-20. PubMed ID: 22012890
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structural basis for CD44 recognition by ERM proteins.
    Mori T; Kitano K; Terawaki S; Maesaki R; Fukami Y; Hakoshima T
    J Biol Chem; 2008 Oct; 283(43):29602-12. PubMed ID: 18753140
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Self-masking in an intact ERM-merlin protein: an active role for the central alpha-helical domain.
    Li Q; Nance MR; Kulikauskas R; Nyberg K; Fehon R; Karplus PA; Bretscher A; Tesmer JJ
    J Mol Biol; 2007 Feb; 365(5):1446-59. PubMed ID: 17134719
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Crystallization and preliminary crystallographic analysis of the ezrin FERM domain.
    Smith WJ; Cerione RA
    Acta Crystallogr D Biol Crystallogr; 2002 Aug; 58(Pt 8):1359-61. PubMed ID: 12136155
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The 2.7 A crystal structure of the activated FERM domain of moesin: an analysis of structural changes on activation.
    Edwards SD; Keep NH
    Biochemistry; 2001 Jun; 40(24):7061-8. PubMed ID: 11401550
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structural basis of the membrane-targeting and unmasking mechanisms of the radixin FERM domain.
    Hamada K; Shimizu T; Matsui T; Tsukita S; Hakoshima T
    EMBO J; 2000 Sep; 19(17):4449-62. PubMed ID: 10970839
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Soluble ezrin purified from placenta exists as stable monomers and elongated dimers with masked C-terminal ezrin-radixin-moesin association domains.
    Bretscher A; Gary R; Berryman M
    Biochemistry; 1995 Dec; 34(51):16830-7. PubMed ID: 8527459
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ezrin self-association involves binding of an N-terminal domain to a normally masked C-terminal domain that includes the F-actin binding site.
    Gary R; Bretscher A
    Mol Biol Cell; 1995 Aug; 6(8):1061-75. PubMed ID: 7579708
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.